Skip to content
PresyoGamot
Menu

Dolutegravir + Lamivudine + Tenofovir price in the Philippines

Quick answer

The DOH reference price for lamivudine + tenofovir + dolutegravir 300 mg + 300 mg + 50 mg bottle 30 tablets per bottle (for reference only) is ₱1,750.00 per tablet (median, June 2024 index); drugstore prices are usually higher. FDA Philippines lists 7 registered dolutegravir + lamivudine + tenofovir products (checked 2026-11-05): 4 as unbranded generics and 3 under 3 brand names. It is a prescription (Rx) medicine. Ask the pharmacist for the unbranded generic of the same strength.

FDA-registered: 7 products3 brandsPrescription (Rx)

Government reference price

Lamivudine + Tenofovir + Dolutegravir 300 mg + 300 mg + 50 mg bottle 30 tablets per bottle (for Reference Only)₱1,750.00DOH reference, median per tablet

At the DOH median, 30 tablets cost about ₱52,500.00, a month at one a day.

DPRI range, DOH DPRI June 2024. What public hospitals pay; drugstore prices are usually higher.

Strengths

Dolutegravir + Lamivudine + Tenofovir by strength

Dolutegravir + Lamivudine + Tenofovir is listed here in 1 strength; 1 of them (50 mg + 300 mg + 300 mg) have FDA-registered products in the Philippines.

Dolutegravir + Lamivudine + Tenofovir by strength
StrengthDOH median (₱)FDA products
Dolutegravir + Lamivudine + Tenofovir 50 mg + 300 mg + 300 mg₱1,750.007

Sources: FDA Philippines registry (2026-11-05), DOH DPRI June 2024.

Registered products

Registered dolutegravir + lamivudine + tenofovir products

FDA Philippines lists 7 registrations under 4 brand names (one row is unbranded generics).

Registered dolutegravir + lamivudine + tenofovir products
BrandStrength and formClassManufacturerReg.
Acriptega300 mg/300 mg/50 mg Film-Coated TabletRxMylan Laboratories Limited (India)1
Kovatraxx50 mg/300 mg/ 300 mg Film-Coated TabletRxMacleods Pharmaceuticals Limited (India)1
Teldy50 mg/300 mg/300 mg Film Coated TabletRxHetero Labs Limited (India)1
No brand (generic)50 mg/300 mg/ 300 mg Film-Coated Tablet; 50 mg/300 mg/300 mg Film-Coated Tablet; 50mg/300mg/300mg Film-Coated TabletRxAPL Healthcare Limited, Unit-IV (India) +3 more4

Source: FDA Philippines product registry, checked 2026-11-05. Look up any registration number at verification.fda.gov.ph.

Official leaflets

The package insert (PI) and patient leaflet (PIL) filed with FDA Philippines. Doses, side effects and warnings are there, written by the maker and approved by FDA.

Paying less for dolutegravir + lamivudine + tenofovir

  • Ask for the generic

    Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works

  • Senior or PWD card

    20% off plus no VAT on your own medicines, with ID and prescription. What to bring

Questions people ask

Do I need a prescription for dolutegravir + lamivudine + tenofovir in the Philippines?

FDA Philippines classifies dolutegravir + lamivudine + tenofovir as a prescription (Rx) medicine. A pharmacist may dispense it only against a valid prescription (Pharmacy Act, RA 10918).

Is there a generic dolutegravir + lamivudine + tenofovir registered in the Philippines?

FDA Philippines lists 7 registered dolutegravir + lamivudine + tenofovir products (checked 2026-11-05): 4 sold under the generic name only and 3 under 3 brand names. Ask the pharmacist for the unbranded generic: same ingredient and strength.

How much does dolutegravir + lamivudine + tenofovir cost in the Philippines?

The DOH Drug Price Reference Index, June 2024 edition, lists lamivudine + tenofovir + dolutegravir 300 mg + 300 mg + 50 mg bottle 30 tablets per bottle (for reference only) at a median of ₱1,750.00 (range ₱1,600.00 to ₱1,900.00). That is what public hospitals pay; drugstore prices are usually higher.

Where can I buy dolutegravir + lamivudine + tenofovir legally?

From an FDA-licensed drugstore or botika; the licence to operate (LTO) should be displayed in the store. Bring your prescription. Check that the box carries a DR- registration number, and be careful with online sellers that are not licensed pharmacies.

Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.